Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England

Freja C M Kirsebom1, Nick Andrews2, Julia Stowe1

  • 1UK Health Security Agency, London NW9 5EQ, UK.

The Lancet. Infectious Diseases
|May 27, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

179
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
179
Cross-reactivity00:42

Cross-reactivity

31.6K
Overview
31.6K
Vaccinations01:51

Vaccinations

45.4K
Overview
45.4K

Articles linked to this work by shared authors, journal, and citation graph.

A cohort study of persons exposed to highly pathogenic avian influenza A(H5N1) at premises with infected animals, England, 2023 to 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.

The Journal of infection·2026

Global approaches to infectious disease surveillance and modeling.

Nature medicine·2026

Large outbreak of group B invasive meningococcal disease in young adults in South East England, March 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.

EClinicalMedicine·2026

The emergence and molecular evolution of H5N1 influenza viruses in United States dairy cattle.

bioRxiv : the preprint server for biology·2026

Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

The Lancet. Infectious diseases·2026

Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study.

The Lancet. Infectious diseases·2026

Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation study.

The Lancet. Infectious diseases·2026

Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications.

The Lancet. Infectious diseases·2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Infectious diseases·2026

Clinical accuracy, performance, and usability of the Dragonfly point-of-care molecular diagnostic platform for mpox: a mixed-methods field evaluation in Uganda.

The Lancet. Infectious diseases·2026

Sex-specific cardiac remodeling and metabolic reprogramming in IUGR F2 fetuses following glyphosate or glyphosate-based herbicide exposure.

Frontiers in toxicology·2026

BioCNT-TLS engineered systemic mobile resistome for sustainable crop protection.

Frontiers in plant science·2026

MaizeGDB Phylostrata Tool: exploring evolutionary origins of maize proteins.

Bioinformatics advances·2026

Development of a 10K breeder-friendly SNP chip for faba bean.

Frontiers in plant science·2026

Beyond bacterial dysbiosis: the emerging role of gut bacteriophages in type 2 diabetes.

Frontiers in cell and developmental biology·2026

A streamlined protocol for small-scale protoplast generation and CRISPR/Cpf1-mediated genome editing in Fusarium oxysporum.

iScience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us